Mesoblast Limited Asset Turnover Ratio (MESO), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Mesoblast Limited  (NASDAQ: MESO)
 

Mesoblast Limited Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Mesoblast Limited asset turnover ratio, the ability of Mesoblast Limited's assets to generate revenue in the fourth quarter 2025, increased sequentially to 0.02 in the fourth quarter (Jun 30 2025), yet the ratio remained below the average, as MESO's position remain challenging.

Within sector 56 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from 3235 to 3540.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MESO Asset Turnover Ratio (Jun 30 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Jun 30 2024)
IV. Quarter
Y / Y Asset Change 4.71 % 61.87 % 0.1 % 61.87 % -0.84 %
Y / Y Revenue Change 191.39 % - - - -21.32 %
Asset Turnover Ratio (TTM) 0.02 - - - 0.01
MESO's Total Ranking # 3540 # 3235 # # #
Seq. Asset Change 0.57 % 3.86 % -3.72 % 4.12 % 55.46 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 57
Healthcare Sector # 499
Overall Market # 3540

Asset Turnover Ratio Statistics
High Average Low
0.04 0.02 0.01
(Jun 30 2020)   (Jun 30 2024)




MESO Company Profile • Back to MESO Efficiency Comparisons • Compare MESO Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2025 Assets at quarter ending Jun 30 2025
Therapeuticsmd Inc   0.06 $ 2.246  Millions$ 38.922  Millions
Solana Company  0.06 $ 0.295  Millions$ 5.126  Millions
Mountain Crest Acquisition Corp V  0.06 $ 0.141  Millions$ 2.468  Millions
Recursion Pharmaceuticals Inc   0.05 $ 64.596  Millions$ 1,195.672  Millions
Biorestorative Therapies Inc   0.05 $ 0.605  Millions$ 11.424  Millions
Intellia Therapeutics Inc   0.05 $ 52.857  Millions$ 1,062.356  Millions
Prophase Labs Inc   0.05 $ 3.029  Millions$ 61.790  Millions
Viskase Holdings inc   0.05 $ 2.198  Millions$ 46.187  Millions
Beam Therapeutics Inc   0.05 $ 60.272  Millions$ 1,283.317  Millions
Orchestra Biomed Holdings Inc   0.05 $ 2.944  Millions$ 63.342  Millions
Grail Inc   0.05 $ 134.285  Millions$ 2,912.854  Millions
Seer Inc   0.05 $ 16.135  Millions$ 354.942  Millions
Bolt Biotherapeutics Inc   0.05 $ 4.167  Millions$ 92.582  Millions
Immunome Inc   0.04 $ 12.589  Millions$ 284.030  Millions
Kymera Therapeutics Inc   0.04 $ 44.711  Millions$ 1,015.564  Millions
Blue Water Vaccines Inc  0.04 $ 1.327  Millions$ 31.999  Millions
Scynexis Inc   0.04 $ 3.258  Millions$ 79.573  Millions
Taysha Gene Therapies Inc   0.04 $ 8.098  Millions$ 203.069  Millions
Dbv Technologies S a   0.04 $ 3.848  Millions$ 98.193  Millions
Northwest Biotherapeutics Inc  0.04 $ 1.094  Millions$ 28.275  Millions
Nexalin Technology Inc   0.04 $ 0.175  Millions$ 4.736  Millions
Bellevue Life Sciences Acquisition Corp  0.04 $ 3.532  Millions$ 95.798  Millions
Pluri Inc   0.04 $ 1.336  Millions$ 37.765  Millions
Astrotech Corp  0.03 $ 1.049  Millions$ 29.983  Millions
Instil Bio Inc   0.03 $ 8.751  Millions$ 251.141  Millions
Abeona Therapeutics Inc   0.03 $ 4.949  Millions$ 143.780  Millions
One World Products Inc   0.03 $ 0.005  Millions$ 0.149  Millions
Caribou Biosciences Inc   0.03 $ 9.121  Millions$ 288.052  Millions
Hcw Biologics Inc   0.03 $ 0.833  Millions$ 27.997  Millions
Aligos Therapeutics Inc   0.03 $ 3.174  Millions$ 110.981  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.